The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On April 26, 2026, Medtronic announced continued momentum for the Affera family of technologies for cardiac arrhythmia ...

Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of th ...

Medtronic today announced new milestones for its Affera family of technologies, including an FDA breakthrough device ...

Medtronic plc has scored a CE mark for its Affera mapping and ablation system for atrial arrhythmias, mere months after acquiring the technology from cardiac solutions company Affera Inc. The dual-use ...

First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform The Sphere-9 Catheter, ...

Medtronic plc MDT recently announced the receipt of a CE Mark for the Affera Mapping and Ablation System to treat atrial arrhythmias. The system includes the Sphere-9 Catheter and the Affera Prism-1 ...

GALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ Sphere-360™ catheter, a ...

Medtronic plc, a global leader in healthcare technology, announced two major milestones for the Affera Sphere-360 catheter, a first-of-its-kind, all-in-one mapping and single-shot pulsed field ...